Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-09-22

Clinical Trial Update: The Impact of RPh201 on CVS Patients: Clinical and fMRI Measurements [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating RPh201 in patients with chronic vegetative state (Phase 1 and Phase 2) has been withdrawn. The sponsor listed is Hadassah Medical Orga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RPh201

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Chronic Vegetative State | Phase 1, Phase 2 | Status: WITHDRAWN